About AL-Harmain Pharma
AL-Harmain Pharma is a Healthcare company based in India. Manufacture and distribution of Unani medicines in India. Its Indian entity Al-Harmain Pharma (India) Private Limited reported revenue of ₹40 Lakh. AL-Harmain Pharma offers products and services including Unani Medicines and Khamira Formulations. Its focus areas include Health and Pharmaceuticals, Pharmaceuticals, General Medicines and Herbal Formulations.
Company details
Al-Harmain Pharma is recognized as a leading Indian company in the Unani drugs sector, where Good Manufacturing Practices are applied throughout the production process to deliver quality herbal medicines. Various formulations are offered for treating ailments like joint pain, migraines, and heart conditions, with a focus on traditional remedies for general debility and blood purification. Operations are based in Hapur, Uttar Pradesh, supporting both B2B and B2C models, while adherence to standards ensures efficacy in addressing common diseases.
- Headquarters India
- SectorsHealthcare
- Email••••••••
- Website alharmainpharma.in
- Social LinkedIn Facebook Instagram YouTube
- Legal Name Al-Harmain Pharma (India) Pvt. Ltd.
- Date of Incorporation 02 Sep, 2004
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹40 Lakh
FY 2025 · -69% YoY
- Net Loss-₹98.7 Lakh
FY 2025 · -247% margin
- EBITDA-₹92.4 Lakh
FY 2025 · -231% margin
Associated legal entities of AL-Harmain Pharma
AL-Harmain Pharma operates through Al-Harmain Pharma (India) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Al-Harmain Pharma (India) Private Limited CIN U24232DL2004PTC128769 | Active | 02 Sep 2004 | New Delhi, Delhi | ₹0.4 Cr | 30 | 2 | View details |
Products & Services of AL-Harmain Pharma
AL-Harmain Pharma offers a comprehensive portfolio of products and services, including Unani Medicines and Khamira Formulations.
Unani medicines are manufactured for addressing various ailments including heart and brain conditions
Khamira formulations are provided as tonics that strengthen the heart and brain while aiding in debility management
Apps and channels of AL-Harmain Pharma
its YouTube channel AL-HARMAIN PHARMA | Unani Drugs Manufacturer has 147 subscribers and 7 videos.
Videos from AL-Harmain Pharma
The most watched videos on AL-Harmain Pharma's YouTube channel, AL-HARMAIN PHARMA | Unani Drugs Manufacturer (147 subscribers). Click a video to play it here.
Board of directors of Al-Harmain Pharma (India) Private Limited (AL-Harmain Pharma)
Al-Harmain Pharma (India) Private Limited is the primary company behind AL-Harmain Pharma. The board of Al-Harmain Pharma (India) Private Limited currently have 2 directors; the longest-serving is Mohd Tariq, appointed in 2004. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mohd Tariq DIN 01276189 | Director | 02 Sep 2004 | 22 yrs 1 mo | Al-Harmain Pharma (India) Private Limited |
| Saboor Ahmed Siddiqui DIN 02050814 | Director | 02 Sep 2004 | 22 yrs 1 mo | Al-Harmain Pharma (India) Private Limited |
Financials of AL-Harmain Pharma
Figures of Al-Harmain Pharma (India) Private Limited, the primary company behind AL-Harmain Pharma, for FY 2025. Revenue was ₹40 Lakh (-69% year on year). Net loss was -₹98.7 Lakh (-247% margin). EBITDA was -₹92.4 Lakh (-231% margin). Revenue has grown at a compounded annual rate of -67% over three years and -49% over five years.
- ₹40 LakhRevenue · FY 2025 · -69% YoY
- -₹98.7 LakhNet loss · -247% margin
- -₹92.4 LakhEBITDA · -231% margin
- ₹1.62 CrPaid-up capital
- 30Employees (provident fund records)
- -67%Revenue CAGR, 3 years
- -49%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Al-Harmain Pharma (India) Private Limited are on its company page.
Detailed financial statements for AL-Harmain Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AL-Harmain Pharma
AL-Harmain Pharma is headquartered in India.
The primary company behind AL-Harmain Pharma, Al-Harmain Pharma (India) Private Limited, reported revenue of ₹40 Lakh for FY 2025, down 69% year on year.
Al-Harmain Pharma is recognized as a leading Indian company in the Unani drugs sector, where Good Manufacturing Practices are applied throughout the production process to deliver quality herbal medicines. Various formulations are offered for treating ailments like joint pain, migraines, and heart conditions, with a focus on traditional remedies for general debility and blood purification. Operations are based in Hapur, Uttar Pradesh, supporting both B2B and B2C models, while adherence to standards ensures efficacy in addressing common diseases.
AL-Harmain Pharma offers Unani Medicines and Khamira Formulations.
AL-Harmain Pharma operates through Al-Harmain Pharma (India) Private Limited.
The legal entities of AL-Harmain Pharma currently have 2 directors, including Mohd Tariq, Saboor Ahmed Siddiqui.